UBS Downgrades Baldwin Insurance to Neutral, Lowers Price Target to $32.5

Benzinga Newsdesk www.benzinga.com Negative 91.1%

Neg 91.1% Neu 0% Pos 0%

UBS analyst Brian Meredith downgrades Baldwin Insurance (NASDAQ:BWIN) from Buy to Neutral and lowers the price target from $37 to $32.5.